The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead
The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead
复制标题
DOI：
10.1017/jme.2021.3
复制
发表时间：
2021-01-01
影响因子：
2.1
通讯作者：
Sampat, Bhaven N.
中科院分区：
文献类型：
--
作者：
Sampat, Bhaven N.
目前关于公共和私营部门在制药创新中的作用的争论由来已久。公共部门支持药物创新的程度和方式对评估公共研究资金的回报、纳税人在药物中的权利、支持药物创新需要高价格的论点以及为公共资助的研究申请专利的可取性都有影响。
Current debates about the roles of the public and private sectors in pharmaceutical innovation have a long history. The extent to which, and ways in which, the public sector supports drug innovation has implications for assessments of the returns to public research funding, taxpayer rights in drugs, the argument the high prices are needed to support drug innovation, and the desirability of patenting publicly funded research.